Category: neuroendocrine cancer
A Possible Cure for Neuroendocrine Cancer: Exciting Update!
Back in September 2012 we shared the following: “For $1.6 million (1 million pounds) an oncolytic virus that has the potential to cure neuroendocrine cancer can be named for the donor. At Uppsala University in Sweden researchers are ready to start a …
READ MORE
I Have Cancer. And I’ve Never Felt Better!
Imagine nine years of debilitating gastrointestinal illness; misdiagnoses from doctors that include gastroparesis, pancreatitis, functional dyspepsia, Irritable Bowel Syndrome (IBS), and being told to reduce the stress in your life; a battery…
READ MORE
NETumor Humor Benefit
“If you’re laughing about it, you’re talking about it.” Comedic performances by Greg Fitzsimmons, Frangela, Adam Ray, Andie Bolt, Eliana Horeczko, Fortune Feimster and more will be featured during the NEtTumor Humor Benefit at the Westside…
READ MORE
First U.S. Center to Enroll Patients in International, Multicenter Clinical Trial of Lu-177 Octreotate
Excel Diagnostics and Nuclear Oncology Center in Houston, Texas, is the first center in the United States to start recruiting patients in a multicenter randomized clinical trial of Lu-177 Octreotate in patients with progressive midgut carcinoid. …
READ MORE
FDA Approves Amendment for PRRT Clinical Trial in Texas
BREAKING NEWS: The Food and Drug Administration (FDA) has just approved the RadioIsotope Therapy of America (RITA) Foundation’s amendment to the Investigational New Drug (IND) protocol for intra-hepatic artery administration of Lu-177 Octreotate…
READ MORE
Mud Cats Little League Baseball Game in Virginia Raises Awareness and Funds for Carcinoid Cancer
Go Mud Cats!!! Cheer on the Mud Cats Little League baseball team on Saturday, June 2, 2012 at 4 pm, Edgar Tillet Memorial Park, in Loudoun County, Virginia, when the team plays its annual “Friends and Family” game. This year’s game will focus on carcinoid…
READ MORE
Social Media Connects Carcinoid and Neuroendocrine Cancer Survivors
Denise Passehl, a carcinoid cancer survivor, will share her experience with social media when she participates in the 140 Characters Conference on April 23 in Des Moines, Iowa. The focus of the conference, designed by Jeff Pulver, is how “real time technology…
READ MORE
Lexicon Pharmaceuticals Granted Orphan Drug Designation by FDA for Carcinoid Syndrome Treatment
Lexicon Pharmaceuticals, Inc. has been granted Orphan Drug Designation for telotristat etiprate (LX1032) by the U.S. Food and Drug Administration (FDA). LX1032 is used to treat carcinoid syndrome, a chronic condition caused by neuroendocrine tumors,…
READ MORE
New England Carcinoid Connection (NECC) Announces June 2012 Conference
Carcinoid and neuroendocrine cancer patients, family members, caregivers, and healthcare professionals are invited to attend the New England Carcinoid Connection Conference on Friday, June 8, 2012 at The Lantana in Randolph, Massachusetts. The…
READ MORE
Multiple Endocrine Neoplasia (MEN) Type 1 Seminar Scheduled for June 2012 at Mayo Clinic
MEN, carcinoid, and neuroendocrine cancer patients, family members, caregivers, advocacy groups, physicians, and healthcare professionals are invited to attend the Multiple Endocrine Neoplasia Type 1 Seminar presented by American Multiple Endocrine…
READ MORE